Group One Trading
GRTX

Group One Trading’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Group One Trading’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,500
Closed -$364 – 8180
2023
Q4 		$364 Sell
2,500
-53,100
-96% -$8.25K ﹤0.01% 7121
2023
Q3 		$9.74K Buy
55,600
+13,900
+33% +$17.3K ﹤0.01% 6353
2023
Q2 		$130K Sell
41,700
-214,900
-84% -$639K ﹤0.01% 4354
2023
Q1 		$657K Buy
256,600
+252,400
+6,010% +$521K ﹤0.01% 2503
2022
Q4 		$6.26K Sell
4,200
-53,300
-93% -$86.5K ﹤0.01% 6238
2022
Q3 		$100K Buy
57,500
+3,500
+6% +$4.95K ﹤0.01% 4781
2022
Q2 		$70K Sell
54,000
-254,400
-82% -$436K ﹤0.01% 5292
2022
Q1 		$734K Buy
308,400
+263,100
+581% +$685K ﹤0.01% 3410
2021
Q4 		$208K Buy
+45,300
New +$150K ﹤0.01% 5053

Other funds holding GRTX

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Group One Trading's GRTX Position: Q2 2024 in Review

Group One Trading sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 32,720 shares — an estimated $4.58K sold.

Group One Trading first reported a position in GRTX in Q4 2021 and held it in 8 quarters. The position peaked at $315K in Q4 2021. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

  • Group One Trading reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Group One Trading sold 32,720 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $4.58K.
  • Group One Trading first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • Group One Trading's Galera Therapeutics, Inc. Common Stock position peaked at $315K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.